Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VALSARTAN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 27 adverse event reports in the FDA FAERS database where VALSARTAN was used for Atrial fibrillation.

Most Reported Side Effects for VALSARTAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,845 8.5% 43 469
Blood pressure increased 1,682 7.7% 40 430
Dizziness 1,527 7.0% 116 573
Headache 1,361 6.3% 24 534
Hypertension 1,341 6.2% 53 505
Acute kidney injury 1,301 6.0% 78 901
Dyspnoea 1,239 5.7% 84 674
Fatigue 1,156 5.3% 75 517
Malaise 1,139 5.2% 31 453
Hypotension 1,032 4.8% 78 622
Nausea 962 4.4% 41 502
Diarrhoea 864 4.0% 60 431
Cough 857 4.0% 25 346
Fall 812 3.7% 70 558
Weight decreased 766 3.5% 47 463

Other Indications for VALSARTAN

Hypertension (8,956) Product used for unknown indication (8,702) Cardiac failure (496) Blood pressure abnormal (407) Blood pressure measurement (282) Blood pressure increased (206) Cardiac failure chronic (140) Cardiac disorder (136) Essential hypertension (113) Foetal exposure during pregnancy (71)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

VALSARTAN Full Profile All Atrial fibrillation Drugs VALSARTAN Demographics VALSARTAN Timeline